SCHEMBL6186925

SCHEMBL6186925

CC(O)CN1CCNC(Oc2ccc3oc(-c4ccccc4)nc3c2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACSL1 P33121 1/20 0.47
ACACB O00763 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.39
POLB P06746 3/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
CASP3 P42574 2/20 0.39
SENP7 Q9BQF6 2/20 0.39
SENP6 Q9GZR1 2/20 0.39
KDM4E B2RXH2 2/20 0.39
HPGD P15428 1/20 0.39
SENP8 Q96LD8 1/20 0.39
TLR9 Q9NR96 2/20 0.39
MAPT P10636 3/20 0.38
HDAC6 Q9UBN7 2/20 0.37
ALDH1A1 P00352 2/20 0.37
TLR7 Q9NYK1 1/20 0.36
PTPN2 P17706 1/20 0.36
PTPN1 P18031 1/20 0.36
PTPN5 P54829 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6188783 0.93 TLR9 (0.47) ACSL1ACACBTLR9TLR7
SCHEMBL6188276 0.91 NPC1 (0.43) ACSL1SMN1; SMN2NPC1RAB9ACASP3
SCHEMBL6185575 0.80 NPC1 (0.40) SMN1; SMN2POLBNPC1RAB9AKDM4E
SCHEMBL6192472 0.78 ACSL1 (0.43) ACSL1ACACBSMN1; SMN2POLBNPC1
SCHEMBL6186053 0.75 CYP3A4 (0.41)
SCHEMBL6185748 0.73 NPC1 (0.34) NPC1RAB9AHDAC6KMT2A
SCHEMBL6185503 0.73 L3MBTL1 (0.39) SMN1; SMN2NPC1RAB9AKDM4EHPGD
SCHEMBL5901370 0.73 PKM (0.49) ACSL1SMN1; SMN2POLBKDM4ETLR9
SCHEMBL5965265 0.73 PKM (0.49) ACSL1SMN1; SMN2POLBKDM4ETLR9
SCHEMBL4040185 0.73 PKM (0.49) ACSL1SMN1; SMN2POLBKDM4ETLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567525-A2 SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2005-08-31 EP disclosed
WO-2004052887-A2 SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2004-06-24 WO disclosed